NSC2805 |
| Katalog-Nr.GC66427 |
NSC2805 ist ein WWP2-Ubiquitin-Ligase-Inhibitor, der die WWP2-AktivitÄt mit einem IC50-Wert von 0,38 signifikant hemmen kann μM. NSC2805 kann fÜr die Krebsforschung eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 4371-34-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NSC2805 is a WWP2 ubiquitin ligase inhibitor that can significant inhibit WWP2 activity with an IC50 of 0.38 μM. NSC2805 can be used for the research of cancer[1].
NSC2805 has WWP2 inhibitory activity with an IC50 of 0.38 μM[1].
NSC2805 shows a significant reduction in activity for all three proteins (WWP2, WWP1 and Nedd4)[1].
NSC2805 can robustly inhibit WWP2-dependent PTEN ubiquitination[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *